Scientists tested a new oral GLP-1 drug called aleniglipron in 230 adults with obesity at 38 U.S. medical centers.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks
12.1% % Weight loss achieved
230 Adults Trial participants
36 Weeks Trial length
3 (45-120mg) Doses tested
Mild To Moderate Side effects